CPT 96921: Excimer (Ultraviolet) Laser Treatment for Psoriasis, 250–500 sq cm
CPT code 96921 denotes excimer (ultraviolet) laser treatment for psoriasis covering a treatment area of 250–500 square centimeters. This procedure is a targeted dermatologic therapy used to manage localized plaque psoriasis and related ultraviolet-responsive skin conditions. Nationally, the code is relevant for clinical dermatology practices and ambulatory procedure billing due to increasing use of localized phototherapy as an alternative to systemic agents and broad-field phototherapy.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find an overview of how the service is defined, typical sites of service, and the clinical context in which 96921 is billed. The publication outlines common coding relationships, adjacent size-based CPT codes for smaller and larger treatment areas, and payer coverage patterns and policies where available.
This summary equips revenue cycle leaders, dermatology clinicians, and policy analysts with concise context on clinical application and billing placement of 96921, highlights where it sits among related codes, and identifies what to expect in payer plan review and claims adjudication. Data not available in the input includes specific payer reimbursement rates and plan-level medical necessity criteria.
Customize your policy alerts
Sign up for cpt 96921 policy alerts
Get alerted when payer policies referencing 96921 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 96921 describes treatment of psoriasis using an excimer ultraviolet laser for a total treatment area of 250 to 500 square centimeters. The service is a procedural dermatologic therapy that delivers targeted ultraviolet light to affected skin surfaces.
Service type: Excimer (ultraviolet) laser therapy for psoriasis
Typical site of service: Outpatient dermatology clinic or ambulatory care facility
National Reimbursement Benchmarks
Nationally, Medicare’s mean rate of $154.2 sits well below BUCA’s commercial average of $252.4, highlighting a substantial gap between government and this commercial benchmark. Medicare’s interquartile band ($142 to $160) is narrow, reflecting consistency across its 47 localities, while BUCA’s central tendency ($178.1 to $319.3 for the 25th–75th percentiles) indicates higher average payment levels and broader middle dispersion among commercial plans.
Dispersion measured as P75 minus P25 is tightest for Aetna at $115.0 (P75 $150.0 minus P25 $35.4) and tight for Medicare at $18.0 (P75 $160 minus P25 $142). The widest spreads appear for Blue Cross Blue Shield at $144.6 and UnitedHealth Group at $146.7, with Cigna and BUCA showing intermediate interquartile ranges of $153.6 and $141.2 respectively, signaling more variability in commercial contracting compared with Medicare.